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Abstract 
Background:  Conventional reconstruction after an esophagectomy uses a gastric tube which 
commonly causes several postoperative complaints such as gastric acid reflux in long term 
survival cases. Intestinal interposition between the remnant esophagus and the stomach is an 
option to reduce complaints, and in this study the advantages of jejunal interposition 
reconstruction with a stomach preserving esophagectomy (SPE) were assessed. 
Materials and methods:  Eleven cases of jejunal interposition with an SPE and 16 cases with 
gastric tube reconstruction as a control were subject to a comparison of operation time, amount 
of bleeding, postoperative QOL and endoscopic findings. 
Results:  The SPE group had a longer operation time (SPE: 560 ± 121 min, control 414 ± 83 
min, P = 0.038), whereas there was no significant difference in blood loss. Postoperative weight 
loss was significantly recovered in the SPE group (SPE vs control = 94.0 ± 5.4% vs 87.5 ± 4.7% 
at 3 months, P = 0.017; 97.2 ± 7.5% vs 85.0 ± 5.2% at 6 months, P = 0.010) and there was a 
significant decrease in the occurrence of reflux symptoms such as heartburn, odynophagia and 
cough when jejunal interposition with an SPE was done. Furthermore, reflux esophagitis and 
Barrett’s epithelium were found in 6 out of 12 cases (50%) of the control group by postoperative 
endoscopy, while no cases in the SPE group had either condition (P < 0.01). 
Conclusions:  This reconstruction method is a promising option to improve postoperative 
QOL, mainly due to the long-term elimination of reflux esophagitis, which assists in the 
recovery of postoperative weight loss. 
Key Words:  esophageal cancer; jejunal interposition reconstruction; stomach preserving 
esophagectomy; postoperative QOL; reflux esophagitis. 
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Introduction 
Surgical treatments for esophageal cancer are highly invasive, and esophageal cancer 
often has perioperative complications [1-3]. Additionally, conventional reconstructions, such as 
gastric tube reconstruction, have more than a few cases with a low quality of life (QOL) and 
weight loss even in long-term survival cases. The low QOL cases are due to gastrointestinal 
symptoms such as heartburn caused by dysphagia and the back-flow of gastric acid [4]. The 
weight loss is due to the difficulty of oral intake [4, 5]. Furthermore, there are some cases in 
which complications from under-nutrition and pneumonia have caused death. 
There are reports about colonic interpositions which preserved gastric functions after 
an esophagectomy. Reports have shown that colonic interposition is advantageous due to a 
higher calorie intake and better postoperative body weight recovery [6]. It is not difficult to 
imagine that the small intestine can be an alternative tissue for interposition after an 
esophagectomy and our team has performed this technique for middle and lower esophageal 
cancers called a Stomach Preserving Esophagectomy (SPE). An SPE is a reconstruction method 
done by interposing the pedunculated jejunum in the posterior mediastinal route and elevating 
the jejunum. This surgical method interposes the jejunum so that the direct back-flow of gastric 
acid to the remnant esophagus can be controlled and therefore alleviate reflux symptoms. 
Compared to gastric tube reconstruction, from the point of view of gastric emptying and the 
capability of the stomach, this method also increases the amount of oral intake because gastric 
function is highly preserved. Therefore, an improvement in postoperative QOL and the 
preservation of digestive and absorptive functions are possible. 
In this paper, a detailed description of our version of the SPE surgical procedure and 
data obtained from the procedure are shown. Additionally, both postoperative QOL and 
nutritional status were compared with gastric tube reconstruction surgeries retrospectively, and 
the significance of SPE was examined. 
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Materials and Methods 
Indication and surgical procedure for SPE 
The indication of SPE is based upon the site of primary tumor, which should be below 
the middle of the thoracic esophagus. This limitation is because the anastomosis of the remnant 
esophagus to the jejunum should be lower than the aortic arch. In addition, suspicious lymph 
nodal metastases in the superior mediastinal area are an exclusion criterion. Obviously, cases 
whose tumors have massively invaded the stomach and those with stomach cancer are not 
candidates for SPE.  
A surgical procedure for SPE consists of two steps, namely removal of the esophagus 
and reconstitution; 
Removal procedures: The patient’s body was fixed onto an operating table with the left 
side angled downward 45 degrees. When operating on the patient’s abdominal and thoracic 
areas, the table was rotated to be capable of a simultaneous approach to both the thoracic and 
abdominal areas, and this body positioning is useful when lifting the jejunum into the thoracic 
cavity. The Skin incision in the abdomen is from the xiphoid process to the navel and in the 
thoracic area there is usually a small anterior axillary incision (8 to 10 cm) from the 4th segment 
of the ribs. First, in the supine position, dissect the lymph nodes around the stomach. Then 
dissect the left gastric artery and vein in due form and then remove the anal side (gastric side) at 
the gastric cardia. Next is the lower mediastinal manipulation. After ligating and dissecting the 
left subdiaphragmatic vein, open up the esophageal hiatus and perform the lymph node 
dissection and removal of the esophagus as close to the cephalic side as possible while 
compressing the pericardium and parietal pleura. For cases that require cervical lymph node 
dissection, abdominal manipulation is necessary at the same time. After the lower mediastinal 
dissection of the transdiaphragmatic hiatus, rotate the table to bring the body to a supine 
position with the left side down, and proceed with the thoracic manipulation. 
In most cases, the dissection of the esophagus is completed close to the tracheal 
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bifurcation due to the previous dissection of the transdiaphragmatic hiatus in the abdominal area. 
Therefore, the area of esophagus removed by the thoracic procedure is small. Lymph node 
dissection in the thoracic cavity is performed as in due form and then move the gastric cardia 
was moved up into the thoracic cavity in order to prepare for the reconstruction. 
Reconstruction procedures: Bring the body to a supine position again to treat the 
jejunum. Before taking care of the blood vessels, isolate the small intestine membrane from the 
ileocecal region to the Treitz ligament (Fig. 1A). At this time in the procedure, it is important to 
remove the superior mesenteric artery and vein completely to the pancreatic dorsum (Fig. 1B). 
Following the same procedure, elevating the jejunum often becomes advantageous because it 
can give an extra 5 to 8 cm for the later suture procedure, and the lifting of the reconstructed 
intestinal tract into the thoracic cavity can also be performed safely. When treating the blood 
vessels of the jejunum, the second and third jejunal arteries and veins are often dissected (Fig. 
1C). After the vessel treatment, use an autosuture to dissect the jejunum that is appropriate for 
elevating 20 cm from the Treitz ligament (Fig. 1D). Then lift the jejunum into the thoracic 
cavity using the transhiatus approach through the transverse mesocolon and the back of the 
stomach (Fig. 1E). 
The esophageal jejunum suture is performed by overlapping sutures using a variable 
laparoscopic linear stapler (Fig. 2A-C). Representative intraoperative pictures for Fig. 2A-C are 
also shown as Fig. 2D-F, respectively. When closing up the chest leave the thoracic drainage 
tube in. Then the stomach-jejunum suture and the jejunum-jejunum suture are done, adding a 
finger fracture pyloromyotomy as is also done for gastric tube reconstructions. Finally, a 
drainage tube is inserted after constructing a jejunal fistula. 
The schematic view of a completed reconstruction of jejunal interposition for SPE is 
shown in Fig. 3. In this study, we did not dare to preserve the vagus nerve due to full lymph 
node dissection. 
Assessment of long-term postoperative QOL in comparison to conventional reconstruction 
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with a gastric tube 
Between October 2006 and May 2009, eleven patients had a stomach preserving 
esophagectomy (SPE) following the indications for an SPE; 1) below the middle of the thoracic 
esophagus, 2) no lymph nodal metastasis in the superior mediastinal area, 3) informed consent 
for SPE. Sixteen patients with esophageal cancer below the middle of the thoracic esophagus 
who had a conventional gastric tube reconstruction during the same period were used as the 
control group. We measured the operation duration and the amount of bleeding to compare 
between the SPE group and the control group. In order to evaluate the function of gastric 
absorption, albumin, total protein values and body weight decrease were monitored once a 
month for six months after surgery. To evaluate the QOL, a questionnaire from the European 
Organization for Research and Treatment of Cancer (EORTC) for assessing the quality of life 
for patients with esophageal cancer (QLQ-OES18) was used as a reference [7,8], and data was 
collected by phone survey on reflux symptoms, vomiting, heartburn, dysphagia, odynophagia, 
cough and aspiration. The phone survey was conducted at a single time point in February, 2010. 
This means that the follow-up time from the operation varies between 9-36 months for the 27 
cases enrolled in this study. 
Endoscopic evaluation of postoperative reflux esophagitis after an esophagectomy 
An upper gastrointestinal endoscopy was done for cases with postoperative reflux 
symptoms. The level of mucosal damage in the esophagus, small intestine, the anastomosis area 
of the esophagus and the stomach was evaluated according to the Los Angeles classification [9], 
and the existence of residual dross was also examined.  
Statistical analysis 
JMP5.0.1J software was used to perform a t-test and a chi-square test, with a P < 0.05 
considered to be significant. 
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Results 
Jejunal interposition with a stomach preserving esophagectomy preserves postoperative 
gastric peristalsis 
A postoperative esophagogram showed that the sutured site of the residual esophagus 
and pedunculated jejunum is positioned at the subcarinal level. Contrast agent flowed smoothly 
from the pedunculated jejunum to the preserved stomach (Fig. 4A). Of note, the contrast agent 
temporarily pooled in the stomach, and then gradually flowed to the duodenum (Fig. 4B), 
suggesting that the preserved stomach appeared to maintain its peristaltic action regardless of 
possible damage to the vagus nerve from lymph node dissection.  
Comparison of long-term postoperative QOL with gastric tube reconstruction 
Table 1 shows the details of the cases enrolled in this study. The male-female ratio of 
the SPE group was 5:6, and 9:7 for the control group. The average age was 65.3 ± 11.6 years old 
for the SPE group, and 56.9 ± 11.0 years old for the control group, meaning the control group 
tended to be younger (P = 0.02). The SPE group had more cases whose tumors infiltrated only 
down to the submucosal layer, whereas the control group contained some deeper invasive cases. 
However, there was no significant difference regarding the depth of invasion. There were no 
clear tendencies in lymph node metastasis or histological types (Table 1). 
The operative duration of the SPE group and the control group were 506 ± 121 
minutes and 414 ± 83 minutes, respectively, indicating that the SPE needed more time to be 
completed (P = 0.038). The amount of bleeding in the SPE and control groups were 579 ± 403 
ml and 558 ± 353 ml, respectively, with no significant difference (P = 0.895). 
There was not a significant difference in the total protein and albumin values (Fig. 5A 
and B). Interestingly, the difference in the recovery of body weight after surgery was significant 
at both 3 months and 6 months (3 months: SPE vs control = 94.0 ± 5.4% vs 87.5% ± 4.7%, P = 
0.017; 6 months: SPE vs control = 97.2% ± 7.5% vs 85.0% ± 5.2%, P = 0.010; Fig. 5C). 
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We performed a phone survey to assess the subjective symptoms related to upper 
gastrointestinal function based upon the EORTC questionnaire (QLQ-OES18). The phone 
survey response rate was 81.5% (22 out of 27 cases). Eight of 11 SPE cases responded (72.7%) 
and 14 of 16 control cases replied to the survey (87.5%). Among the respondents, reflux 
symptoms, vomiting, dysphagia and aspiration did not show a significant difference between the 
SPE and control groups. However, the SPE group had fewer symptoms that are characteristic of 
reflux esophagitis such as heartburn, odynophagia and cough (Table 2 and Supplementary 
Figure). 
Furthermore, there was no endoscopic finding of reflux esophagitis in the SPE group, 
whereas mucosal damage due to reflux esophagitis appeared in the control group (P = 0.05). Of 
note, no Barrett’s epithelium appeared in the SPE group while this mucosal change significantly 
occurred in the control group (SPE: 0 out of 6 endoscopic cases, control: 6 out of 12 cases; P < 
0.01) (Table 3 and Fig. 6). These observations suggest that jejunal interposition for SPE seems 
to improve some of the major postoperative complaints, body weight loss, and reflux 
esophagitis and its related symptoms. 
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Discussion 
Our SPE method, which is a novel technique because of the elevation of the 
pedunculated jejunum to the anastomosis site for reconstruction, can be good for the control of 
reflux symptoms. This procedure is mainly adapted for lower thoracic esophageal cancer, but is 
also suitable for Barrett’s esophageal cancer, which is more common in North America and 
Europe [10-12]. In consideration of intestinal continuity after an esophageal resection, it is 
technically difficult to elevate the pedunculated jejunum to the high thoracic or cervical position 
in the mediastinum, thus from the perspective of the degree of free elevation, ileocolic 
interposition is often adapted [13, 14]. 
There was not a significant difference regarding the amount of bleeding, but the 
operative duration of the SPE group was significantly longer. This is likely because an SPE has 
three anastomosis parts whereas a gastric tube reconstruction only has a single anastomosis. 
Also treatments for blood flow of the reconstructed small intestine differ slightly depending on 
each case due to the variety of body figures and vascularity, and this can also be considered as a 
factor for the longer operation time. 
The number of esophageal cancer cases that survive more than five years after an 
esophagectomy is increasing, however little is known of the functional status and QOL of 
long-term survivors after a curative resection for esophageal cancer. McLarty et al. surveyed 
359 cases that underwent an esophagectomy, and showed that the overall 10-year and 15-year 
survival was less than the expected survival of a normal population. The postoperative QOL 
survey showed that 60% of patients had heartburn, 29% required antacid for the relief of 
heartburn, 37% ate less, and 49% never regained body weight that they lost after the operation 
[4]. Some reports also showed that colonic interposition with cervical anastomosis reduced the 
incidence of reflux and relieved the weight loss after the operation [5]. Akiyama et al. showed 
gastric function preserving intestinal continuity after an esophageal resection through a blunt 
esophagectomy with vagus nerve preservation [15]. Ando et al. also reported on colonic 
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interposition preserving stomach function with a vagotomy, and the study showed that their 
colonic interposition maintained a superior QOL because the procedure enabled patients to take 
in more calories and prevented postoperative body weight loss [6].  
Similar to these previous studies, our current study also revealed a significant 
improvement of postoperative body weight loss in the SPE group compared to the control group 
(Fig. 5C). When Doki et al. studied the reconstruction of the small intestine after an 
esophagectomy by the subcutaneous reconstruction route and compared it to ileocolic 
reconstruction, the body weight decrease was less for the reconstruction of the small intestine 
than the ileocolic reconstruction [16]. Since an unintentional decrease in weight of 10-15% 
within 3-6 months is considered to be malnutrition [17] and it is well recognized that 
malnutrition affects increased rates of complication, mortality, morbidity and the poor quality of 
life after surgery, the improvement of postoperative body weight should contribute to a better 
quality of life with reduced complications after surgery. In this study, the postoperative body 
weight recovery in the SPE group was significantly better than in the control group, possibly 
contributing to less complications and a better quality of life compared to those in gastric tube 
group.  
Reflux symptoms, vomiting, dysphagia and aspiration did not show a significant 
difference between the groups, but heartburn, odynophagia and cough showed a significant 
decrease in the SPE group. These symptoms are highly associated with reflux esophagitis, and 
these results also corresponded with the endoscopic findings. Reflux symptoms often cause a 
loss of appetite, which is possibly one of the reasons for the difficulty regaining body weight 
after an esophagectomy with conventional reconstructions. Thus, an SPE is a promising option 
to overcome these complaints.  
In support of the questionnaire results, the endoscopic findings also showed that the 
SPE group had a significant decrease in the development of reflux esophagitis. It is possible that 
using antacid can have a long-term protective effect on the remnant esophagus and the 
development of Barrett’s epithelium in the SPE cases. In the control group, there were severe 
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esophagitis cases that needed strong antacid treatment. In the endoscopic therapeutic course of 
these cases, most of the regrown epithelium was replaced by Barrett’s epithelium and spread 
circularly from the anastomosis upwards. Therefore, in regard to the range of the development 
of Barrett’s epithelia, the SPE group showed less reflux acid exposure than the control group. 
As a point of reference, D'Journo et al. reported that mucosal damage in the remnant 
esophagus at a cervical anastomosis is pathologically different from that of an intrathoracic 
anastomosis [18]. Although the mucosa of the remnant esophagus was found to be freer of 
damage over time in patients with a cervical anastomosis than those with an intrathoracic 
anastomosis, they also reported that all patients showed a graded gastric-type and cardiac-type 
metaplasia and also showed intestinal metaplasia regardless of the kind of anastomosis. If the 
mucosal status of the remnant esophagus indicates reflux esophagitis, it can be considered that 
jejunal interposition prevents the remnant esophagus from developing reflux esophagitis, and 
the fact that jejunal interposition for SPE keeps normal mucosa in the long term indicates a 
superior postoperative long-term QOL improvement. 
It is important to note that this SPE procedure is limited to approximately 20% of 
esophageal cancer cases due to our current indications that the tumor location should be below 
the middle of the thoracic esophagus and that there should be no lymph nodal metastasis in the 
superior mediastinal area. It is unlikely that these anatomical properties can be overcome in the 
near term.  
In conclusion, the fact cannot be evaded that an SPE is a technically complicated 
procedure and has an increased operation time. However, it has enough advantages to cover 
these disadvantages, and an SPE can improve postoperative gastrointestinal symptoms and 
prevent reflux esophagitis. Moreover, an SPE significantly contributes to improving 
postoperative body weight loss. Therefore, an SPE is considered to be a superior procedure for 
patient’s postoperative QOL compared to more conventional procedures. 
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Table 1. Clinicopathologic characteristics of esophageal cancer cases in this study 
SPE 
(n = 11) 
Control 
(n = 16) 
Total 
(n = 27) 
p 
Sex Male 5 9 14 0.1548 
Female 6 7 13 
Age＊ 65.3 ± 11.6 56.9 ± 11.0 62.9 ± 17.3 0.0293＊ 
Main 
location✝ 
Cervical 0 0 0 0.8089 
Ut 0 2 2 
Mt 5 11 16 
Lt 7 4 11 
Abdominal 3 1 4 
Depth of m・sm 8 11 21 0.6881 
invasion mp 1 0 1 
adv 2 5 7 
Lymph node N0 7 10 17 0.6184 
metastasis N1 2 1 3 
N2 2 5 7 
Stage 1A 6 9 15 0.6077 
1B 1 0 1 
2A 0 1 1 
2B 2 2 4 
3A 1 2 3 
3B 1 2 3 
Histology SCC 9 16 25 0.7937 
Adeno 1 0 1 
SCC＋Adeno 1 0 1 
16 
＊Indicates significance (P < 0.05) . 
✝ Cases invading multiple regions were calculated for each region. 
Abbreviations: Ut: upper thoracic, Mt: middle thoracic, Lt: lower thoracic, m: mucosa, sm: 
submucosa, mp: muscularis propria, adv: adventitia, SCC: squamous cell carcinoma, Adeno: 
adenocarcinoma, SPE: stomach preserving esophagectomy. 
N0: No lymph node metastasis, N1: Metastasis involving only Group 1 lymph nodes, and N2: 
Metastasis to Group 2 lymph nodes. Definitions of Lymph node groups and Stage are according 
to the Japanese Classification of Esophageal Cancer (Tenth edition) edited by the Japan 
Esophageal Society [19]. 
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Table 2. Postoperative quality questionnaire results 
SPE 
(n = 8) 
Control 
(n = 14) 
p 
Reflex symptoms 3 (37.5%) 9 (64.3%) 0.22 
Vomiting 2 (25%) 4 (28.6%) 0.85 
Heart burn 1 (12.5%) 8 (57.1%) 0.03* 
Dysphagia 5 (62.5%) 9 (64.3%) 0.93 
Odynophagia 0 (0%) 4 (28.6%) 0.04* 
Cough 1 (12.5%) 8 (57.1%) 0.03* 
Aspiration 1 (12.5%) 5 (35.7%) 0.22 
*Indicates significance.
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Table 3. Endoscopic findings of the residual esophagus and anastomosis 
SPE 
(n = 8) 
Control 
(n = 12) 
p 
Residue 2(25.0%) 4(33.3%) 0.53 
Barrett`s epithelium 0(0%) 6(50.0%) 0.005* 
Reflux Esophagitis A 0(0%) 3(25.0%) 
(Los-Angeles classification) B 0(0%) 2(16.7%) 
C 0(0%) 1(8.3%) 




Figure 1. Schematic views of preparing the pedunculated jejunum for reconstruction 
Several key steps of the surgical procedure for the preparation of the pedunculated 
jejunum to be elevated to the intrathoracic anastomosis site are shown in graphics (A-C). 
Schematic images of elevating the pedunculated jejunum are also shown in D and E. 
Figure 2. Schematic process of intrathoracic esophago-jejunal anastomosis of jejunal 
interposition for a stomach-preserving esophagectomy 
Several key steps of anastomosis between the remnant esophagus and the elevated 
pedunculated jejunum are shown in graphics (A-C) as well as in the corresponding 
intraoperative photos (D-F). 
Figure 3. Schematic view of the reconstruction with jejunal interposition for a stomach 
preserving esophagectomy (SPE)  
After the esophagectomy, the pedunculated jejunum is elevated via the posterior 
mediastinum route for reconstruction with the remnant esophagus and preserved stomach.  
Figure 4. Radiographic contrast imaging of jejunal interposition for an SPE 
Contrast agent flowed smoothly from the pedunculated jejunum to the preserved 
stomach (A), temporarily pooled in the stomach, and then gradually flowed to the duodenum 
with apparent gastric peristalsis (B). 
Figure 5. Postoperative change of nutrition status and body weight 
The serum concentrations of total protein (A) and albumin (B) were tracked every 
month after surgery. Six months after surgery, the value of total protein was; SPE: 6.95 ± 0.07 
g/dl, Control: 6.65 ± 0.38 g/dl, P = 0.33. Six months after surgery, the value of albumin was; 
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SPE: 4.05 ± 0.35 g/dl, Control: 4.00 ± 0.33 g/dl, P = 0.86. (C) The body weight of each 
participant was also tracked every month to compare the SPE and the control. Three months 
after surgery, the recovery rate of each group was; SPE: 94.0 ± 5.4 %, control: 87.5 ± 4.7 %, P = 
0.017, and after six months; SPE: 97.2 ± 7.5 %, control: 85.0 ± 5.2 %, P = 0.010. 
Figure 6. Endoscopic findings around the anastomosis 
Conventional gastric tube reconstruction developed Barrett’s epithelium eight months 
after surgery (A and B), whereas jejunal interposition for an SPE showed a clear anastomosis 
line and no reflex epithelium change by endoscopic observation (C and D). 
Supplementary figure. Comparison of numeric scores for the grading or intensity of the 
postoperative quality questionnaire (QLQ-OES18) 
The actual numeric scores from the answers to the postoperative quality questionnaire 
(QLQ-OES18) are illustrated in a histogram to compare between patients with gastric tube 
reconstruction (A) and those with an SPE (B). Each numeric score represents the following 
answers; 1 for “not at all”, 2 for “a little”, 3 for “quite a bit”, and 4 for “very much”.   
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